Feasibility of Plasma-Methylated <i>SFRP2</i> for Early Detection of Gastric Cancer.

Cancer Control · 2020 · PMC7218304 · PMID 32379490

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Particularly, the mean Cp values of methylated SFRP2 showed a decreasing trend across stage I to IV, and the mean Cp values for GC and IM patients were significantly lower than those for GFGP, AP, HP, and control patients, showing a pattern consist with that of positive detection rates shown in Figure 2A and B .

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.